{"id":983234,"date":"2026-07-21T09:39:43","date_gmt":"2026-07-21T13:39:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/"},"modified":"2026-07-21T09:39:43","modified_gmt":"2026-07-21T13:39:43","slug":"exagen-to-announce-second-quarter-financial-results-on-august-4-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/","title":{"rendered":"Exagen to Announce Second Quarter Financial Results on August 4, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>CARLSBAD, Calif., July  21, 2026  (GLOBE NEWSWIRE) &#8212; Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended June 30, 2026, before the market opens on Tuesday, August 4, 2026. John Aballi, President and Chief Executive Officer, and Jeff Black, Chief Financial Officer, will host a conference call at 8:30 a.m. ET (5:30 a.m. PT) that morning to review the Company\u2019s results.<\/p>\n<p>\n        <strong>Conference Call and Webcast:<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>U.S. dial-in:<\/strong> 877-407-0890<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>International dial-in:<\/strong> +1 201-389-0918<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Webcast:<\/strong> Available via the Exagen Investor Relations website at <a href=\"https:\/\/investors.exagen.com\/\" rel=\"nofollow\" target=\"_blank\">investors.exagen.com<\/a><\/li>\n<\/ul>\n<p>\n        <strong>Replay:<\/strong> A telephone replay will be available until Tuesday, August 18, 2026:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>U.S. replay:<\/strong> 877-660-6853<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>International replay:<\/strong> +1 201-612-7415<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Replay passcode:<\/strong> 13760979<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <strong>Webcast:<\/strong> A recording of the webcast will be available one hour after the call concludes via the Exagen Investor Relations website at <a href=\"https:\/\/investors.exagen.com\/\" rel=\"nofollow\" target=\"_blank\">investors.exagen.com<\/a><\/li>\n<\/ul>\n<p>\n        <strong>About\u00a0Exagen Inc.<\/strong>\n      <\/p>\n<p>Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, California, Exagen\u2019s mission is to provide clarity in autoimmune disease decision-making and improve clinical outcomes through its innovative testing portfolio. The company\u2019s flagship product, AVISE\u00ae CTD, enables clinicians to more effectively diagnose complex autoimmune conditions such as lupus, rheumatoid arthritis, and Sj\u00f6gren\u2019s disease earlier and with greater accuracy. Exagen\u2019s CLIA-certified, CAP-accredited laboratory specializes in the testing of rheumatic diseases, delivering precise and timely results, supported by a suite of AVISE-branded tests for disease diagnosis, prognosis, and monitoring. With a focus on research, innovation, education, and patient-centered care, Exagen is dedicated to addressing the ongoing challenges of autoimmune disease management.<\/p>\n<p>For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-lmGmPdiMs82IAGBlgVmLFoNm7uIpndfMeSUewUAO2qlnBIVltVDcNb7ZbrSiR97Or8f4vxVOha9YA4CXU9PjA==\" rel=\"nofollow\" target=\"_blank\">Exagen.com<\/a> or follow Exagen on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SSuk1b1CB9QzDpQHWP8VkfVLs83CSGjORxyDLUbcBpD50_s3RyRbipG6_0KeBm-zVGMQewolIu5VyEpBLxgksDtb-PjsxNjT3LzwxjRBKUrb0StR8pbpmZMt-KTFduAMhHq-f_DiWAr59Toi3aTalQ==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Contact<\/strong>\n      <\/p>\n<p>Tina Jacobsen, CFA<br \/>Exagen Inc.<br \/>ir@exagen.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjE3NSM3NzA2MjEwIzIwMTA5NzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDQ0ZTliMGUtYTkwOS00ZDQyLTg0OTQtOTQwMjM2OTgwZmI2LTEwMjI1NDUtMjAyNi0wNy0yMS1lbg==\/tiny\/Exagen-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CARLSBAD, Calif., July 21, 2026 (GLOBE NEWSWIRE) &#8212; Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended June 30, 2026, before the market opens on Tuesday, August 4, 2026. John Aballi, President and Chief Executive Officer, and Jeff Black, Chief Financial Officer, will host a conference call at 8:30 a.m. ET (5:30 a.m. PT) that morning to review the Company\u2019s results. Conference Call and Webcast: U.S. dial-in: 877-407-0890 International dial-in: +1 201-389-0918 Webcast: Available via the Exagen Investor Relations website at investors.exagen.com Replay: A telephone replay will be available until Tuesday, August 18, 2026: U.S. replay: 877-660-6853 International replay: +1 201-612-7415 Replay passcode: 13760979 Webcast: A recording of the webcast &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Exagen to Announce Second Quarter Financial Results on August 4, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-983234","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Exagen to Announce Second Quarter Financial Results on August 4, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exagen to Announce Second Quarter Financial Results on August 4, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CARLSBAD, Calif., July 21, 2026 (GLOBE NEWSWIRE) &#8212; Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended June 30, 2026, before the market opens on Tuesday, August 4, 2026. John Aballi, President and Chief Executive Officer, and Jeff Black, Chief Financial Officer, will host a conference call at 8:30 a.m. ET (5:30 a.m. PT) that morning to review the Company\u2019s results. Conference Call and Webcast: U.S. dial-in: 877-407-0890 International dial-in: +1 201-389-0918 Webcast: Available via the Exagen Investor Relations website at investors.exagen.com Replay: A telephone replay will be available until Tuesday, August 18, 2026: U.S. replay: 877-660-6853 International replay: +1 201-612-7415 Replay passcode: 13760979 Webcast: A recording of the webcast &hellip; Continue reading &quot;Exagen to Announce Second Quarter Financial Results on August 4, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-21T13:39:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjE3NSM3NzA2MjEwIzIwMTA5NzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Exagen to Announce Second Quarter Financial Results on August 4, 2026\",\"datePublished\":\"2026-07-21T13:39:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\\\/\"},\"wordCount\":300,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2MjE3NSM3NzA2MjEwIzIwMTA5NzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\\\/\",\"name\":\"Exagen to Announce Second Quarter Financial Results on August 4, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2MjE3NSM3NzA2MjEwIzIwMTA5NzI=\",\"datePublished\":\"2026-07-21T13:39:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2MjE3NSM3NzA2MjEwIzIwMTA5NzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2MjE3NSM3NzA2MjEwIzIwMTA5NzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exagen to Announce Second Quarter Financial Results on August 4, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exagen to Announce Second Quarter Financial Results on August 4, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/","og_locale":"en_US","og_type":"article","og_title":"Exagen to Announce Second Quarter Financial Results on August 4, 2026 - Market Newsdesk","og_description":"CARLSBAD, Calif., July 21, 2026 (GLOBE NEWSWIRE) &#8212; Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended June 30, 2026, before the market opens on Tuesday, August 4, 2026. John Aballi, President and Chief Executive Officer, and Jeff Black, Chief Financial Officer, will host a conference call at 8:30 a.m. ET (5:30 a.m. PT) that morning to review the Company\u2019s results. Conference Call and Webcast: U.S. dial-in: 877-407-0890 International dial-in: +1 201-389-0918 Webcast: Available via the Exagen Investor Relations website at investors.exagen.com Replay: A telephone replay will be available until Tuesday, August 18, 2026: U.S. replay: 877-660-6853 International replay: +1 201-612-7415 Replay passcode: 13760979 Webcast: A recording of the webcast &hellip; Continue reading \"Exagen to Announce Second Quarter Financial Results on August 4, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-21T13:39:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjE3NSM3NzA2MjEwIzIwMTA5NzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Exagen to Announce Second Quarter Financial Results on August 4, 2026","datePublished":"2026-07-21T13:39:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/"},"wordCount":300,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjE3NSM3NzA2MjEwIzIwMTA5NzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/","name":"Exagen to Announce Second Quarter Financial Results on August 4, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjE3NSM3NzA2MjEwIzIwMTA5NzI=","datePublished":"2026-07-21T13:39:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjE3NSM3NzA2MjEwIzIwMTA5NzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2MjE3NSM3NzA2MjEwIzIwMTA5NzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-to-announce-second-quarter-financial-results-on-august-4-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Exagen to Announce Second Quarter Financial Results on August 4, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/983234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=983234"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/983234\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=983234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=983234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=983234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}